Administration, Cutaneous
"Administration, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
Concept/Terms
Administration, Cutaneous- Administration, Cutaneous
- Administration, Dermal
- Administrations, Dermal
- Dermal Administrations
- Dermal Administration
- Cutaneous Administration
- Administrations, Cutaneous
- Cutaneous Administrations
- Skin Administration, Drug
- Drug Skin Administrations
- Skin Administrations, Drug
- Drug Administration, Cutaneous
- Administration, Cutaneous Drug
- Administrations, Cutaneous Drug
- Cutaneous Drug Administrations
- Drug Administrations, Cutaneous
- Cutaneous Drug Administration
- Dermal Drug Administration
- Administration, Dermal Drug
- Administrations, Dermal Drug
- Dermal Drug Administrations
- Drug Administrations, Dermal
- Drug Administration, Dermal
- Skin Drug Administration
- Skin Drug Administrations
- Cutaneous Administration, Drug
- Cutaneous Administrations, Drug
Administration, Transcutaneous- Administration, Transcutaneous
- Administrations, Transcutaneous
- Transcutaneous Administrations
- Administration, Transdermal
- Administrations, Transdermal
- Transdermal Administrations
- Transdermal Administration
- Transcutaneous Administration
Percutaneous Administration- Percutaneous Administration
- Administration, Percutaneous
- Administrations, Percutaneous
- Percutaneous Administrations
Below are MeSH descriptors whose meaning is more general than "Administration, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Cutaneous".
This graph shows the total number of publications written about "Administration, Cutaneous" by people in Harvard Catalyst Profiles by year, and whether "Administration, Cutaneous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 1 | 2 |
| 1994 | 1 | 3 | 4 |
| 1995 | 2 | 13 | 15 |
| 1996 | 2 | 13 | 15 |
| 1997 | 1 | 6 | 7 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 6 | 6 |
| 2000 | 1 | 5 | 6 |
| 2001 | 0 | 12 | 12 |
| 2002 | 0 | 14 | 14 |
| 2003 | 0 | 18 | 18 |
| 2004 | 1 | 6 | 7 |
| 2005 | 1 | 9 | 10 |
| 2006 | 0 | 18 | 18 |
| 2007 | 1 | 16 | 17 |
| 2008 | 0 | 19 | 19 |
| 2009 | 0 | 17 | 17 |
| 2010 | 0 | 19 | 19 |
| 2011 | 1 | 16 | 17 |
| 2012 | 0 | 22 | 22 |
| 2013 | 0 | 17 | 17 |
| 2014 | 1 | 18 | 19 |
| 2015 | 0 | 20 | 20 |
| 2016 | 1 | 14 | 15 |
| 2017 | 1 | 21 | 22 |
| 2018 | 2 | 16 | 18 |
| 2019 | 1 | 13 | 14 |
| 2020 | 0 | 16 | 16 |
| 2021 | 0 | 14 | 14 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 2 | 2 |
Below are the most recent publications written about "Administration, Cutaneous" by people in Profiles.
-
Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease. Nat Commun. 2023 02 16; 14(1):869.
-
Polymeric microneedles enable simultaneous delivery of cancer immunomodulatory drugs and detection of skin biomarkers. Theranostics. 2023; 13(1):1-15.
-
Cutaneous Permeation of a Percutaneously Applied Glucocorticoid Using Plant-Based Anionic Phospholipids in Hydrogenated Vegetable Oil: A Preliminary Study. Medicina (Kaunas). 2022 Sep 23; 58(10).
-
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition. J Am Acad Dermatol. 2023 Mar; 88(3):711-714.
-
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade. J Am Acad Dermatol. 2023 02; 88(2):485-487.
-
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay-Reply. JAMA Dermatol. 2022 06 01; 158(6):705-706.
-
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy. Am J Clin Dermatol. 2022 Jul; 23(4):499-514.
-
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy. J Am Acad Dermatol. 2023 01; 88(1):246-249.
-
The dose-duration effect on cutaneous pharmacokinetics of metronidazole from topical dermatological formulations in Yucatan mini-pigs. Eur J Pharm Biopharm. 2022 Jun; 175:43-52.
-
Bilateral lower extremity induration in a patient with leiomyosarcoma. Lancet Oncol. 2021 10; 22(10):e466.